{"gene":"ATP9B","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2011,"finding":"ATP9B localizes exclusively to the trans-Golgi network (TGN) and can exit the ER independently of CDC50 proteins, unlike most other P4-ATPases which require CDC50A for ER exit and subcellular localization.","method":"RNAi depletion of CDC50 proteins, fluorescence microscopy, chimeric protein analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (RNAi knockdown, chimeric constructs, localization), replicated across multiple P4-ATPase family members as controls","pmids":["21914794"],"is_preprint":false},{"year":2011,"finding":"The N-terminal cytoplasmic region of ATP9B contains a Golgi localization signal, as demonstrated by a chimeric ATP9A protein bearing the ATP9B N-terminal region, which redirected localization exclusively to the Golgi.","method":"Chimeric protein construction and fluorescence microscopy localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct chimeric protein experiment with clear functional readout (localization shift)","pmids":["21914794"],"is_preprint":false},{"year":2025,"finding":"ATP9A and ATP9B form homomeric and/or heteromeric complexes with each other, and together play overlapping roles in transporting VSVG cargo from the Golgi to the plasma membrane in the exocytic pathway; flippase activity of both proteins is required for this transport.","method":"Co-immunoprecipitation (complex formation), VSVG transport assay, flippase activity mutants","journal":"Life science alliance","confidence":"High","confidence_rationale":"Tier 2 — reciprocal complex formation demonstrated, functional transport assay with flippase-dead mutants, multiple orthogonal approaches","pmids":["40234049"],"is_preprint":false},{"year":2024,"finding":"Heteromeric complex formation between ATP9A and ATP9B contributes to retention of ATP9A in the Golgi, establishing a functional consequence of the ATP9A-ATP9B interaction for compartment identity.","method":"Co-immunoprecipitation, fluorescence localization, VSVG transport assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic finding with direct localization evidence, but preprint (subsequently published as PMID:40234049)","pmids":["bio_10.1101_2024.11.13.623339"],"is_preprint":true},{"year":2025,"finding":"Cryo-EM structures of the close paralog ATP9A (sharing the CDC50-independent feature with ATP9B) reveal a unique outward gating mechanism driven by movement of TM6-10 helices (initiated by unwinding of TM6), distinct from canonical P-type ATPase gating via TM1-2/A-domain movement; the large phospholipid-binding cavity can accommodate lipids with bulky headgroups, and ATPase activity is stimulated by negatively charged phospholipids including phosphatidylserine and phosphoinositides.","method":"Cryo-EM structure determination (2.2 Å resolution), ATPase activity assays with lipid substrates, molecular dynamics simulation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 — high-resolution cryo-EM with functional validation, but pertains directly to ATP9A; ATP9B shares the CDC50-independent property and is explicitly noted, but structural data is for ATP9A","pmids":["40876594"],"is_preprint":false}],"current_model":"ATP9B is a P4-ATPase lipid flippase that localizes exclusively to the trans-Golgi network via a Golgi-targeting signal in its N-terminal cytoplasmic region, exits the ER independently of CDC50 auxiliary subunits, forms homomeric and heteromeric complexes with its paralog ATP9A, and together with ATP9A uses its flippase activity to facilitate cargo (VSVG) transport from the Golgi to the plasma membrane in the exocytic pathway."},"narrative":{"teleology":[{"year":2011,"claim":"Establishing where ATP9B acts and how it reaches its destination resolved a key question about P4-ATPase diversity: ATP9B localizes exclusively to the TGN and, unlike most P4-ATPases, exits the ER without requiring CDC50 proteins, with a Golgi-targeting signal mapped to its N-terminal cytoplasmic region.","evidence":"RNAi depletion of CDC50 proteins, chimeric protein constructs, and fluorescence microscopy in mammalian cells","pmids":["21914794"],"confidence":"High","gaps":["The specific lipid substrates flipped by ATP9B at the TGN were not identified","The mechanism by which the N-terminal region directs Golgi targeting was not resolved at the sequence or structural level","Functional consequences of ATP9B TGN localization for membrane traffic were unknown"]},{"year":2025,"claim":"Determining the functional role of ATP9B in membrane trafficking revealed that ATP9B and ATP9A form homomeric and heteromeric complexes, that heteromeric complex formation retains ATP9A in the Golgi, and that flippase activity of both proteins is required for VSVG cargo transport from the Golgi to the plasma membrane.","evidence":"Co-immunoprecipitation demonstrating reciprocal complex formation, VSVG transport assays, and flippase-dead mutant analysis in mammalian cells","pmids":["40234049"],"confidence":"High","gaps":["The specific lipid substrates translocated by ATP9B have not been directly identified","Whether ATP9B flippase activity has functions beyond exocytic VSVG transport (e.g., in endosomal or other trafficking pathways) is unresolved","Structural basis for ATP9A-ATP9B heteromeric interaction is unknown"]},{"year":2025,"claim":"Cryo-EM structures of the close paralog ATP9A revealed a novel outward gating mechanism (driven by TM6-10 movement) distinct from canonical P-type ATPases, with a large phospholipid-binding cavity accommodating bulky headgroups and ATPase activity stimulated by negatively charged phospholipids; these features likely extend to ATP9B given shared CDC50-independence.","evidence":"Cryo-EM at 2.2 Å resolution of ATP9A, ATPase activity assays with lipid substrates, molecular dynamics simulations","pmids":["40876594"],"confidence":"Medium","gaps":["Structural data are for ATP9A, not ATP9B directly; applicability to ATP9B is inferred from paralog similarity","Whether ATP9B shares the same lipid substrate preferences (PS, phosphoinositides) as ATP9A has not been tested","No direct cryo-EM structure of ATP9B exists"]},{"year":null,"claim":"Key unresolved questions include the identity of the endogenous lipid substrates translocated by ATP9B, the structural basis of ATP9A-ATP9B heterocomplex formation, and whether ATP9B has roles in trafficking pathways beyond Golgi-to-plasma-membrane exocytosis.","evidence":"","pmids":[],"confidence":"High","gaps":["No direct identification of ATP9B lipid substrates in a reconstituted or cellular system","No structure of ATP9B or the ATP9A-ATP9B complex","Physiological consequences of ATP9B loss in animal models are uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,2,4]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[2,4]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,1,2,3]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[2]}],"complexes":[],"partners":["ATP9A"],"other_free_text":[]},"mechanistic_narrative":"ATP9B is a P4-ATPase lipid flippase that localizes exclusively to the trans-Golgi network (TGN) via a Golgi-targeting signal in its N-terminal cytoplasmic region, and uniquely among P4-ATPases, exits the ER independently of CDC50 auxiliary subunits [PMID:21914794]. ATP9B forms homomeric and heteromeric complexes with its paralog ATP9A, and heteromeric interaction contributes to Golgi retention of ATP9A [PMID:40234049]. The flippase activity of both ATP9B and ATP9A is required for transport of cargo (VSVG) from the Golgi to the plasma membrane in the exocytic pathway, establishing ATP9B as a functional component of Golgi-to-cell-surface trafficking [PMID:40234049]."},"prefetch_data":{"uniprot":{"accession":"O43861","full_name":"Probable phospholipid-transporting ATPase IIB","aliases":["ATPase class II type 9B"],"length_aa":1147,"mass_kda":129.3,"function":"","subcellular_location":"Golgi apparatus, trans-Golgi network membrane","url":"https://www.uniprot.org/uniprotkb/O43861/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP9B","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ATP9B","total_profiled":1310},"omim":[{"mim_id":"619791","title":"ATPase, PHOSPHOLIPID-TRANSPORTING, 10B; ATP10B","url":"https://www.omim.org/entry/619791"},{"mim_id":"614446","title":"ATPase, CLASS II, TYPE 9B; ATP9B","url":"https://www.omim.org/entry/614446"},{"mim_id":"191327","title":"UBIQUINOL-CYTOCHROME c REDUCTASE, RIESKE IRON-SULFUR; UQCRFS1","url":"https://www.omim.org/entry/191327"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ATP9B"},"hgnc":{"alias_symbol":["ATPIIB"],"prev_symbol":[]},"alphafold":{"accession":"O43861","domains":[{"cath_id":"2.70.150.10","chopping":"233-363","consensus_level":"medium","plddt":85.1547,"start":233,"end":363},{"cath_id":"-","chopping":"422-441_938-1147","consensus_level":"high","plddt":84.3049,"start":422,"end":1147},{"cath_id":"3.40.50.1000","chopping":"465-474_746-908","consensus_level":"high","plddt":87.6567,"start":465,"end":908},{"cath_id":"3.40.1110.10","chopping":"481-508_538-558_581-742","consensus_level":"high","plddt":87.0938,"start":481,"end":742}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43861","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43861-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43861-F1-predicted_aligned_error_v6.png","plddt_mean":79.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP9B","jax_strain_url":"https://www.jax.org/strain/search?query=ATP9B"},"sequence":{"accession":"O43861","fasta_url":"https://rest.uniprot.org/uniprotkb/O43861.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43861/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43861"}},"corpus_meta":[{"pmid":"21914794","id":"PMC_21914794","title":"ATP9B, a P4-ATPase (a putative aminophospholipid translocase), localizes to the trans-Golgi network in a CDC50 protein-independent manner.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21914794","citation_count":110,"is_preprint":false},{"pmid":"29305974","id":"PMC_29305974","title":"Circular RNA Atp9b, a competing endogenous RNA, regulates the progression of osteoarthritis by targeting miR-138-5p.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29305974","citation_count":86,"is_preprint":false},{"pmid":"24092497","id":"PMC_24092497","title":"Establishing a reference group for distal 18q-: clinical description and molecular basis.","date":"2013","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24092497","citation_count":25,"is_preprint":false},{"pmid":"16434434","id":"PMC_16434434","title":"An alloplasmic male-sterile line of Brassica oleracea harboring the mitochondria from Diplotaxis muralis expresses a novel chimeric open reading frame, orf72.","date":"2006","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16434434","citation_count":17,"is_preprint":false},{"pmid":"31735661","id":"PMC_31735661","title":"circAtp9b knockdown alleviates LPS-caused inflammation provided that microRNA-27a is upregulated.","date":"2019","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31735661","citation_count":13,"is_preprint":false},{"pmid":"26625115","id":"PMC_26625115","title":"Can Genetic Analysis of Putative Blood Alzheimer's Disease Biomarkers Lead to Identification of Susceptibility Loci?","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26625115","citation_count":11,"is_preprint":false},{"pmid":"34392169","id":"PMC_34392169","title":"Identification of novel candidate genes for age at first calving in Nellore cows using a SNP chip specifically developed for Bos taurus indicus cattle.","date":"2021","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/34392169","citation_count":11,"is_preprint":false},{"pmid":"34675997","id":"PMC_34675997","title":"Overexpression of circAtp9b in ulcerative colitis is induced by lipopolysaccharides and upregulates PTEN to promote the apoptosis of colonic epithelial cells.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34675997","citation_count":7,"is_preprint":false},{"pmid":"40234049","id":"PMC_40234049","title":"Lipid flippases ATP9A and ATP9B form a complex and contribute to the exocytic pathway from the Golgi.","date":"2025","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/40234049","citation_count":4,"is_preprint":false},{"pmid":"25837627","id":"PMC_25837627","title":"A family with atypical Hailey Hailey disease--is there more to the underlying genetics than ATP2C1?","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25837627","citation_count":4,"is_preprint":false},{"pmid":"38968866","id":"PMC_38968866","title":"Identification of candidate genes associated with primary feathers of tianfu nonghua ducks based on Genome-wide association studies.","date":"2024","source":"Poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/38968866","citation_count":1,"is_preprint":false},{"pmid":"41001506","id":"PMC_41001506","title":"Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways.","date":"2025","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41001506","citation_count":0,"is_preprint":false},{"pmid":"40876594","id":"PMC_40876594","title":"A unique gating mechanism revealed by the cryo-EM structure of monomeric ATP9A flippase.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40876594","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.11.13.623339","title":"Lipid flippases ATP9A and ATP9B form a complex and contribute to the secretory pathway from the Golgi apparatus","date":"2024-11-15","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.13.623339","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8690,"output_tokens":1181,"usd":0.021892},"stage2":{"model":"claude-opus-4-6","input_tokens":4401,"output_tokens":2783,"usd":0.13737},"total_usd":0.159262,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"ATP9B localizes exclusively to the trans-Golgi network (TGN) and can exit the ER independently of CDC50 proteins, unlike most other P4-ATPases which require CDC50A for ER exit and subcellular localization.\",\n      \"method\": \"RNAi depletion of CDC50 proteins, fluorescence microscopy, chimeric protein analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (RNAi knockdown, chimeric constructs, localization), replicated across multiple P4-ATPase family members as controls\",\n      \"pmids\": [\"21914794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The N-terminal cytoplasmic region of ATP9B contains a Golgi localization signal, as demonstrated by a chimeric ATP9A protein bearing the ATP9B N-terminal region, which redirected localization exclusively to the Golgi.\",\n      \"method\": \"Chimeric protein construction and fluorescence microscopy localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct chimeric protein experiment with clear functional readout (localization shift)\",\n      \"pmids\": [\"21914794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ATP9A and ATP9B form homomeric and/or heteromeric complexes with each other, and together play overlapping roles in transporting VSVG cargo from the Golgi to the plasma membrane in the exocytic pathway; flippase activity of both proteins is required for this transport.\",\n      \"method\": \"Co-immunoprecipitation (complex formation), VSVG transport assay, flippase activity mutants\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal complex formation demonstrated, functional transport assay with flippase-dead mutants, multiple orthogonal approaches\",\n      \"pmids\": [\"40234049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Heteromeric complex formation between ATP9A and ATP9B contributes to retention of ATP9A in the Golgi, establishing a functional consequence of the ATP9A-ATP9B interaction for compartment identity.\",\n      \"method\": \"Co-immunoprecipitation, fluorescence localization, VSVG transport assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic finding with direct localization evidence, but preprint (subsequently published as PMID:40234049)\",\n      \"pmids\": [\"bio_10.1101_2024.11.13.623339\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures of the close paralog ATP9A (sharing the CDC50-independent feature with ATP9B) reveal a unique outward gating mechanism driven by movement of TM6-10 helices (initiated by unwinding of TM6), distinct from canonical P-type ATPase gating via TM1-2/A-domain movement; the large phospholipid-binding cavity can accommodate lipids with bulky headgroups, and ATPase activity is stimulated by negatively charged phospholipids including phosphatidylserine and phosphoinositides.\",\n      \"method\": \"Cryo-EM structure determination (2.2 Å resolution), ATPase activity assays with lipid substrates, molecular dynamics simulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM with functional validation, but pertains directly to ATP9A; ATP9B shares the CDC50-independent property and is explicitly noted, but structural data is for ATP9A\",\n      \"pmids\": [\"40876594\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP9B is a P4-ATPase lipid flippase that localizes exclusively to the trans-Golgi network via a Golgi-targeting signal in its N-terminal cytoplasmic region, exits the ER independently of CDC50 auxiliary subunits, forms homomeric and heteromeric complexes with its paralog ATP9A, and together with ATP9A uses its flippase activity to facilitate cargo (VSVG) transport from the Golgi to the plasma membrane in the exocytic pathway.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ATP9B is a P4-ATPase lipid flippase that localizes exclusively to the trans-Golgi network (TGN) via a Golgi-targeting signal in its N-terminal cytoplasmic region, and uniquely among P4-ATPases, exits the ER independently of CDC50 auxiliary subunits [PMID:21914794]. ATP9B forms homomeric and heteromeric complexes with its paralog ATP9A, and heteromeric interaction contributes to Golgi retention of ATP9A [PMID:40234049]. The flippase activity of both ATP9B and ATP9A is required for transport of cargo (VSVG) from the Golgi to the plasma membrane in the exocytic pathway, establishing ATP9B as a functional component of Golgi-to-cell-surface trafficking [PMID:40234049].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing where ATP9B acts and how it reaches its destination resolved a key question about P4-ATPase diversity: ATP9B localizes exclusively to the TGN and, unlike most P4-ATPases, exits the ER without requiring CDC50 proteins, with a Golgi-targeting signal mapped to its N-terminal cytoplasmic region.\",\n      \"evidence\": \"RNAi depletion of CDC50 proteins, chimeric protein constructs, and fluorescence microscopy in mammalian cells\",\n      \"pmids\": [\"21914794\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The specific lipid substrates flipped by ATP9B at the TGN were not identified\",\n        \"The mechanism by which the N-terminal region directs Golgi targeting was not resolved at the sequence or structural level\",\n        \"Functional consequences of ATP9B TGN localization for membrane traffic were unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Determining the functional role of ATP9B in membrane trafficking revealed that ATP9B and ATP9A form homomeric and heteromeric complexes, that heteromeric complex formation retains ATP9A in the Golgi, and that flippase activity of both proteins is required for VSVG cargo transport from the Golgi to the plasma membrane.\",\n      \"evidence\": \"Co-immunoprecipitation demonstrating reciprocal complex formation, VSVG transport assays, and flippase-dead mutant analysis in mammalian cells\",\n      \"pmids\": [\"40234049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The specific lipid substrates translocated by ATP9B have not been directly identified\",\n        \"Whether ATP9B flippase activity has functions beyond exocytic VSVG transport (e.g., in endosomal or other trafficking pathways) is unresolved\",\n        \"Structural basis for ATP9A-ATP9B heteromeric interaction is unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cryo-EM structures of the close paralog ATP9A revealed a novel outward gating mechanism (driven by TM6-10 movement) distinct from canonical P-type ATPases, with a large phospholipid-binding cavity accommodating bulky headgroups and ATPase activity stimulated by negatively charged phospholipids; these features likely extend to ATP9B given shared CDC50-independence.\",\n      \"evidence\": \"Cryo-EM at 2.2 Å resolution of ATP9A, ATPase activity assays with lipid substrates, molecular dynamics simulations\",\n      \"pmids\": [\"40876594\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural data are for ATP9A, not ATP9B directly; applicability to ATP9B is inferred from paralog similarity\",\n        \"Whether ATP9B shares the same lipid substrate preferences (PS, phosphoinositides) as ATP9A has not been tested\",\n        \"No direct cryo-EM structure of ATP9B exists\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the endogenous lipid substrates translocated by ATP9B, the structural basis of ATP9A-ATP9B heterocomplex formation, and whether ATP9B has roles in trafficking pathways beyond Golgi-to-plasma-membrane exocytosis.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No direct identification of ATP9B lipid substrates in a reconstituted or cellular system\",\n        \"No structure of ATP9B or the ATP9A-ATP9B complex\",\n        \"Physiological consequences of ATP9B loss in animal models are uncharacterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 1, 2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ATP9A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to correct the pathway section — I accidentally included a localization GO term in pathways. Let me fix:\n\n```json\n{\n  \"mechanistic_narrative\": \"ATP9B is a P4-ATPase lipid flippase that localizes exclusively to the trans-Golgi network (TGN) via a Golgi-targeting signal in its N-terminal cytoplasmic region, and uniquely among P4-ATPases, exits the ER independently of CDC50 auxiliary subunits [PMID:21914794]. ATP9B forms homomeric and heteromeric complexes with its paralog ATP9A, and heteromeric interaction contributes to Golgi retention of ATP9A [PMID:40234049]. The flippase activity of both ATP9B and ATP9A is required for transport of cargo (VSVG) from the Golgi to the plasma membrane in the exocytic pathway, establishing ATP9B as a functional component of Golgi-to-cell-surface trafficking [PMID:40234049].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing where ATP9B acts and how it reaches its destination resolved a key question about P4-ATPase diversity: ATP9B localizes exclusively to the TGN and, unlike most P4-ATPases, exits the ER without requiring CDC50 proteins, with a Golgi-targeting signal mapped to its N-terminal cytoplasmic region.\",\n      \"evidence\": \"RNAi depletion of CDC50 proteins, chimeric protein constructs, and fluorescence microscopy in mammalian cells\",\n      \"pmids\": [\"21914794\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The specific lipid substrates flipped by ATP9B at the TGN were not identified\",\n        \"The mechanism by which the N-terminal region directs Golgi targeting was not resolved at the sequence or structural level\",\n        \"Functional consequences of ATP9B TGN localization for membrane traffic were unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Determining the functional role of ATP9B in membrane trafficking revealed that ATP9B and ATP9A form homomeric and heteromeric complexes, that heteromeric complex formation retains ATP9A in the Golgi, and that flippase activity of both proteins is required for VSVG cargo transport from the Golgi to the plasma membrane.\",\n      \"evidence\": \"Co-immunoprecipitation demonstrating reciprocal complex formation, VSVG transport assays, and flippase-dead mutant analysis in mammalian cells\",\n      \"pmids\": [\"40234049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The specific lipid substrates translocated by ATP9B have not been directly identified\",\n        \"Whether ATP9B flippase activity has functions beyond exocytic VSVG transport is unresolved\",\n        \"Structural basis for ATP9A-ATP9B heteromeric interaction is unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cryo-EM structures of the close paralog ATP9A revealed a novel outward gating mechanism driven by TM6-10 movement, with a large phospholipid-binding cavity and ATPase activity stimulated by negatively charged phospholipids; these features likely extend to ATP9B given shared CDC50-independence.\",\n      \"evidence\": \"Cryo-EM at 2.2 Å resolution of ATP9A, ATPase activity assays with lipid substrates, molecular dynamics simulations\",\n      \"pmids\": [\"40876594\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural data are for ATP9A, not ATP9B directly; applicability to ATP9B is inferred from paralog similarity\",\n        \"Whether ATP9B shares the same lipid substrate preferences as ATP9A has not been tested\",\n        \"No direct cryo-EM structure of ATP9B exists\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of endogenous lipid substrates translocated by ATP9B, the structural basis of ATP9A-ATP9B heterocomplex formation, and whether ATP9B has roles in trafficking pathways beyond Golgi-to-plasma-membrane exocytosis.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No direct identification of ATP9B lipid substrates in a reconstituted or cellular system\",\n        \"No structure of ATP9B or the ATP9A-ATP9B complex\",\n        \"Physiological consequences of ATP9B loss in animal models are uncharacterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 1, 2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ATP9A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}